搜索临床试验以:safety of booster dose
总计430734个结果
-
Guangzhou Patronus Biotech Co., Ltd.Yantai Patronus Biotech Co., Ltd.尚未招聘
-
Chulalongkorn UniversityHIV-NAT, Thai Red Cross - AIDS Research Centre; Chula Clinical Research Center (Chula CRC),...招聘中单剂 COMVIGEN 疫苗的安全性 | 单剂量 COMVIGEN 疫苗的反应原性 | 单剂量 COMVIGEN 疫苗的免疫原性 | 单剂 BIVALENT 辉瑞/BNT 疫苗的安全性 | 单剂量 BIVALENT Pfizer/BNT 疫苗的反应原性 | 单剂 BIVALENT Pfizer/BNT 疫苗的免疫原性泰国
-
Zhongnan Hospital招聘中SARS-CoV-2 | 安全 | 免疫毒性中国
-
Sinovac Biotech (Colombia) S.A.S.Sinovac Life Sciences Co., Ltd.尚未招聘
-
LG Chem招聘中
-
Federal University of Espirito SantoCentro de Pesquisas René Rachou; Secretaria de Estado da Saúde do Espírito Santo - SESA尚未招聘
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Zhejiang Provincial Center for Disease Control and Prevention招聘中
-
Technovalia, Pty LtdChulalongkorn University; Southern Star Research Pty Ltd.; BioNet-Asia主动,不招人
-
Merck Sharp & Dohme LLC完全的
-
Institute for Clinical and Experimental Medicine主动,不招人
-
GlaxoSmithKline完全的
-
Hipra Scientific, S.L.ULaboratorios Hipra, S.A.完全的新冠肺炎 | SARS-CoV-2 急性呼吸道疾病西班牙
-
Hipra Scientific, S.L.UInstitut d'Investigació Biomèdica de Girona Dr. Josep Trueta; Fundación FLS de Lucha Contra... 和其他合作者完全的
-
Novavax主动,不招人
-
Albert B. Sabin Vaccine InstituteStanford University; Aga Khan University; Oswaldo Cruz Foundation完全的
-
Affiliated Hospital of Yunnan UniversityKunming Medical University; Yunnan University完全的
-
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.Zhejiang Provincial Center for Disease Control and Prevention完全的
-
CanSino Biologics Inc.完全的
-
CinnagenShahid Beheshti University of Medical Sciences; Vaxine Pty Ltd完全的
-
Wuhan Rhegen Biotechnology Co., Ltd.Shenzhen Rhegen Biotechnology Co., Ltd.; Wuhan Recogen Biotechnology Co., Ltd.撤销2019冠状病毒病大流行
-
Guangzhou Patronus Biotech Co., Ltd.Affiliated Hospital of North Sichuan Medical College; Yantai Patronus Biotech Co., Ltd.主动,不招人
-
Guangzhou Patronus Biotech Co., Ltd.Affiliated Hospital of North Sichuan Medical College; Yantai Patronus Biotech Co., Ltd.主动,不招人
-
CanSino Biologics Inc.撤销
-
D'Or Institute for Research and EducationBill and Melinda Gates Foundation主动,不招人
-
Medigen Vaccine Biologics Corp.Coalition for Epidemic Preparedness Innovations完全的
-
Hipra Scientific, S.L.U完全的
-
Hipra Scientific, S.L.U完全的
-
Korea University Guro HospitalKorean Center for Disease Control and Prevention主动,不招人
-
Sinovac Research and Development Co., Ltd.暂停
-
Sinovac Life Sciences Co., Ltd.完全的
-
Arcturus Therapeutics, Inc.终止
-
Sanofi Pasteur, a Sanofi Company完全的赛诺菲巴斯德的联合疫苗在 2、3、4 个月大时作为三剂初级系列接种,随后在 16 至 17 个月大时接种加强剂量,用于先前接受过乙型肝炎剂量的越南婴儿的免疫原性和安全性出生时或出生后 1 周内接种疫苗乙型肝炎 | 百日咳 | 破伤风 | 白喉 | 脊髓灰质炎 | B型流感嗜血杆菌越南
-
Zhejiang Provincial Center for Disease Control...China National Biotec Group Company ltd完全的
-
Novartis VaccinesGlaxoSmithKline完全的